Lance Alstodt, Chairman and CEO of BioRestorative Therapies, Inc. BRTX, was recently interviewed by Benzinga.
BioRestorative Therapies is a cell therapy company that is developing two primary platform technologies. They are harnessing cutting-edge technology in stem cell research to develop treatments that help your own body heal itself.
The company is currently in phase II clinical trials with BRTX-100, a therapy showing promising results in addressing chronic lower back pain. The company has also developed ThermoStem®, a technology addressing metabolic diseases by taking advantage of the body's “healthy fat,” or brown adipose tissue.
Watch the full interview here:
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Featured photo by Pawel Czerwinski on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.